Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A squamous cell carcinoma of the sinonasal tract characterized by a plexiform or ribbon-like growth pattern, cytological atypia, and lack of histological evidence of keratinization.
Biomarker and diagnostic research for non-keratinizing sinonasal squamous cell carcinoma has been reported in the published literature.
No clinical trials have been registered for non-keratinizing sinonasal squamous cell carcinoma.
17 publications have been identified in PubMed for non-keratinizing sinonasal squamous cell carcinoma. Research spans Case Report / Case Series (47%), Review / Meta-Analysis (29%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 47% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 6:58 PM UTC
Research summaries
5 |
29% |
Laboratory research | 2 | 12% |
Testing and diagnosis research | 1 | 6% |
Disease patterns and progression | 1 | 6% |
Bell D (2026). [PMID: 41824150](https://pubmed.ncbi.nlm.nih.gov/41824150/). *Head Neck Pathol*. [Case Report / Case Series]
Chen Y (2026). [PMID: 41588521](https://pubmed.ncbi.nlm.nih.gov/41588521/). *Diagn Pathol*. [Case Report / Case Series]
Velez-Torres JM (2026). [PMID: 41569474](https://pubmed.ncbi.nlm.nih.gov/41569474/). *Head Neck Pathol*. [Review / Meta-Analysis]
Kumar P (2026). [PMID: 41032633](https://pubmed.ncbi.nlm.nih.gov/41032633/). *Int J Surg Pathol*. [Epidemiology / Natural History]
Speakman GC (2026). [PMID: 41173400](https://pubmed.ncbi.nlm.nih.gov/41173400/). *Hum Pathol*. [Review / Meta-Analysis]
Dosemane D (2026). [PMID: 41559320](https://pubmed.ncbi.nlm.nih.gov/41559320/). *Eur Arch Otorhinolaryngol*. [Diagnostic / Biomarker]
Srivastava K (2025). [PMID: 40080145](https://pubmed.ncbi.nlm.nih.gov/40080145/). *Virchows Arch*. [Basic Science / Preclinical]
Owosho AA (2025). [PMID: 39819065](https://pubmed.ncbi.nlm.nih.gov/39819065/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Selkin TR (2025). [PMID: 40944786](https://pubmed.ncbi.nlm.nih.gov/40944786/). *Head Neck Pathol*. [Case Report / Case Series]
Knebel M (2025). [PMID: 40688086](https://pubmed.ncbi.nlm.nih.gov/40688086/). *Front Immunol*. [Case Report / Case Series]
AI-curated news mentioning non-keratinizing sinonasal squamous cell carcinoma
Updated Jul 31, 2026
A study expands the clinicopathologic spectrum of DEK::AFF2 fusion sinonasal tract and skull base nonkeratinizing squamous cell carcinoma, analyzing 50 cases. This research provides valuable insights into the characteristics and implications of this rare cancer type.
A systematic review and meta-analysis examines the impact of genetic and molecular alterations on clinical outcomes in sinonasal squamous cell carcinoma. This research highlights the significance of these alterations in influencing patient prognosis and treatment responses.